EUVIMEDEUVIMED entdecken
Leserbrief

Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”

Zhen-Xin Zeng, Jia-Yi Wu, Shao-Wu Zhuang, Mao-Lin Yan

Hepatology International · 2024

DOI: 10.1007/s12072-024-10682-6 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Hepatology International, 2024. Verfasst von Zhen-Xin Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Phenylurea Compounds, Quinolines. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPhenylurea CompoundsQuinolinesChemoembolization, TherapeuticHumansPrognosisImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

Conversion therapyHepatocellular carcinomaOverall survivalPrognostic modelProgression-free survival

Substanzen

lenvatinibPhenylurea CompoundsQuinolinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
  • Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China.
  • Department of Interventional Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, China.
  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China. yanmaolin74@163.com.
  • Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China. yanmaolin74@163.com.

Zitieren

APA

Zeng, Z. X., Wu, J. Y., Zhuang, S. W., & Yan, M. L. (2024). Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”. Hepatology International. https://doi.org/10.1007/s12072-024-10682-6

Vancouver

Zeng ZX, Wu JY, Zhuang SW, Yan ML. Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”. Hepatology International. 2024. doi:10.1007/s12072-024-10682-6

BibTeX
@article{Zeng2024,
  author = {Zeng, Zhen-Xin and Wu, Jia-Yi and Zhuang, Shao-Wu and Yan, Mao-Lin},
  title = {Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”},
  journal = {Hepatology International},
  year = {2024},
  doi = {10.1007/s12072-024-10682-6}
}
Kostenlos starten →